Laboratory testing of blood metabolite profiles and risk of developing breast cancer in the cancer prevention study II
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201600010A
- Awardee
-
Metabolon, Inc. UEI SBY5A7EK9PU3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $374,000
Award facts
- Opportunity
-
- N02CP6259676 Solicitation number
- FAR 6. 305 Availability of the Justification--REDACTED Justification and Approval Award Notice · Posted Aug 1, 2016
- Acquisition of Laboratory Testing of Blood Metabolite Profiles and Risk of Developing Breast Cancer in the Cancer Prevention Study II Award Notice · Posted Jun 6, 2016
- Contract value 100% obligated
- $374,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27713, USA
Award details come from SAM.gov/FPDS.
About this award
This is a $374,000 firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for laboratory testing of blood metabolite profiles to assess the risk of developing breast cancer as part of the Cancer Prevention Study II. No set-aside was used for this award. Metabolon has extensive experience providing specialized metabolomics analysis services to support federal research initiatives across multiple agencies, including the Department of Veterans Affairs, National Institutes of Health, Food and Drug Administration, Department of Defense, Environmental Protection Agency, and Department of Agriculture. The company holds several indefinite delivery contracts with these agencies, enabling them to issue task orders for ongoing metabolomics testing and analysis requirements.
Quick answers
Who was awarded contract HHSN261201600010A?
HHSN261201600010A was awarded to Metabolon, Inc. by National Cancer Institute (National Institutes of Health) on July 29, 2016.
How much is contract HHSN261201600010A worth?
The government has obligated $374,000 on HHSN261201600010A.
Was contract HHSN261201600010A competed?
The extent of competition for HHSN261201600010A was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award